| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.867 | 0.001 | 0.867 | Nicotinic receptor beta4 subunit antagonist | 0.605 0.001 CID_22943245 0.814 0.001 CID_154699793 0.808 0.001 CID_154699773 0.768 0.001 CID_9813763 | ||
| 0.794 | 0.004 | 0.794 | Psychostimulant | 0.572 0.007 CID_22943245 0.765 0.004 CID_154699793 0.592 0.006 CID_154699773 0.612 0.005 CID_9813763 | ||
| 0.763 | 0.007 | 0.763 | Antiobesity | 0.397 0.067 CID_22943245 0.696 0.011 CID_154699793 0.661 0.014 CID_154699773 0.712 0.01 CID_9813763 | ||
| 0.706 | 0.002 | 0.706 | Adrenaline uptake inhibitor | 0.392 0.004 CID_22943245 0.634 0.003 CID_154699793 0.613 0.003 CID_154699773 0.549 0.003 CID_9813763 | ||
| 0.705 | 0.002 | 0.705 | Dopamine transporter inhibitor | 0.381 0.003 CID_22943245 0.626 0.002 CID_154699793 0.618 0.002 CID_154699773 0.534 0.002 CID_9813763 | ||
| 0.702 | 0.001 | 0.702 | Nicotinic receptor alpha4 subunit antagonist | 0.311 0.003 CID_22943245 0.607 0.002 CID_154699793 0.58 0.002 CID_154699773 0.467 0.002 CID_9813763 | ||
| 0.687 | 0.003 | 0.687 | 5 Hydroxytryptamine uptake inhibitor | 0.286 0.007 CID_22943245 0.589 0.004 CID_154699793 0.549 0.004 CID_154699773 0.496 0.004 CID_9813763 | ||
| 0.652 | 0.001 | 0.652 | Nicotinic alpha3beta2 receptor antagonist | 0.318 0.002 CID_22943245 0.469 0.002 CID_154699793 0.315 0.002 CID_154699773 0.372 0.002 CID_9813763 | ||
| 0.64 | 0.002 | 0.64 | 5 Hydroxytryptamine uptake stimulant | 0.461 0.006 CID_22943245 0.585 0.003 CID_154699793 0.627 0.002 CID_154699773 0.539 0.004 CID_9813763 | ||
| 0.627 | 0.01 | 0.645 | Spasmolytic | 0.522 0.02 CID_22943245 0.645 0.009 CID_154699793 0.595 0.013 CID_154699773 0.632 0.01 CID_9813763 | CID_154699793 | |
| 0.608 | 0.01 | 0.628 | 5 Hydroxytryptamine release inhibitor | 0.605 0.01 CID_22943245 0.57 0.015 CID_154699793 0.539 0.022 CID_154699773 0.628 0.008 CID_9813763 | CID_9813763 | |
| 0.49 | 0.029 | 0.49 | 5 Hydroxytryptamine release stimulant | 0.286 0.074 CID_22943245 0.384 0.049 CID_154699793 0.333 0.061 CID_154699773 0.337 0.059 CID_9813763 | ||
| 0.418 | 0.003 | 0.418 | Nicotinic receptor alpha3 subunit antagonist | 0.233 0.004 CID_22943245 0.367 0.003 CID_154699793 0.189 0.005 CID_154699773 0.185 0.005 CID_9813763 | ||
| 0.377 | 0.003 | 0.377 | Nicotinic alpha4beta2 receptor antagonist | 0.159 0.006 CID_22943245 0.286 0.003 CID_154699793 0.206 0.004 CID_154699773 0.17 0.005 CID_9813763 | ||
| 0.374 | 0.034 | 0.498 | Antiamyloidogenic | 0.239 0.076 CID_22943245 0.498 0.016 CID_154699793 0.391 0.03 CID_154699773 0.242 0.075 CID_9813763 | CID_154699793 | |
| 0.389 | 0.089 | 0.389 | Analgesic | 0.232 0.201 CID_22943245 0.383 0.092 CID_154699793 0.304 0.139 CID_154699773 0.337 0.116 CID_9813763 | ||
| 0.325 | 0.025 | 0.325 | Ca(v)3.3 blocker | 0.281 0.061 CID_22943245 0.269 0.074 CID_154699793 0.266 0.078 CID_154699773 | ||
| 0.296 | 0.004 | 0.296 | Dopamine uptake inhibitor | 0.118 0.014 CID_22943245 0.199 0.006 CID_154699793 0.151 0.01 CID_154699773 0.133 0.012 CID_9813763 | ||
| 0.313 | 0.027 | 0.387 | Tyrosine 3 hydroxylase inhibitor | 0.306 0.03 CID_22943245 0.387 0.009 CID_154699793 0.364 0.013 CID_154699773 0.286 0.04 CID_9813763 | CID_154699793 | |
| 0.279 | 0.017 | 0.279 | 3C-like protease (Human coronavirus) inhibitor | 0.222 0.04 CID_22943245 0.252 0.026 CID_154699793 0.169 0.075 CID_154699773 0.165 0.079 CID_9813763 | ||
| 0.356 | 0.097 | 0.387 | Histamine release inhibitor | 0.387 0.082 CID_22943245 0.363 0.094 CID_154699793 0.316 0.115 CID_154699773 0.297 0.125 CID_9813763 | CID_22943245 | |
| 0.339 | 0.092 | 0.339 | GABA C receptor rho-3 antagonist | 0.236 0.168 CID_22943245 0.326 0.099 CID_154699793 0.255 0.15 CID_154699773 0.206 0.2 CID_9813763 | ||
| 0.251 | 0.005 | 0.251 | Human rhinovirus A protease inhibitor | 0.183 0.006 CID_154699793 0.184 0.006 CID_154699773 0.117 0.013 CID_9813763 | ||
| 0.318 | 0.074 | 0.318 | Vasodilator, coronary | 0.308 0.081 CID_22943245 0.316 0.075 CID_154699793 0.29 0.096 CID_154699773 0.282 0.103 CID_9813763 | ||
| 0.215 | 0.005 | 0.282 | Adrenaline agonist | 0.179 0.009 CID_22943245 0.274 0.004 CID_154699793 0.282 0.004 CID_154699773 0.242 0.005 CID_9813763 | CID_154699773 | |
| 0.218 | 0.013 | 0.218 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.196 0.016 CID_22943245 0.176 0.02 CID_154699793 0.138 0.03 CID_154699773 0.212 0.014 CID_9813763 | ||
| 0.259 | 0.057 | 0.259 | Calpain inhibitor | 0.231 0.083 CID_22943245 0.233 0.081 CID_154699793 0.229 0.085 CID_154699773 0.176 0.14 CID_9813763 | ||
| 0.29 | 0.097 | 0.416 | Cholesterol antagonist | 0.344 0.067 CID_22943245 0.3 0.091 CID_154699793 0.258 0.12 CID_154699773 0.416 0.046 CID_9813763 | CID_9813763 | |
| 0.258 | 0.07 | 0.258 | Gastrin inhibitor | 0.237 0.095 CID_22943245 0.189 0.166 CID_154699793 0.238 0.093 CID_9813763 | ||
| 0.197 | 0.013 | 0.197 | Acetylcholine nicotinic antagonist | 0.11 0.034 CID_22943245 0.184 0.014 CID_154699793 0.129 0.027 CID_154699773 0.1 0.039 CID_9813763 | ||
| 0.228 | 0.051 | 0.244 | Nitric-oxide synthase stimulant | 0.218 0.063 CID_22943245 0.244 0.036 CID_154699793 0.235 0.044 CID_154699773 0.204 0.083 CID_9813763 | CID_154699793 | |
| 0.25 | 0.074 | 0.3 | Superoxide dismutase inhibitor | 0.267 0.065 CID_22943245 0.3 0.051 CID_154699793 0.268 0.064 CID_154699773 0.264 0.066 CID_9813763 | CID_154699793 | |
| 0.197 | 0.026 | 0.197 | Proteasome inhibitor | 0.163 0.039 CID_22943245 0.184 0.03 CID_154699793 0.174 0.034 CID_154699773 0.153 0.045 CID_9813763 | ||
| 0.191 | 0.026 | 0.191 | Antiadrenergic | 0.08 0.071 CID_22943245 0.155 0.034 CID_154699793 0.151 0.036 CID_154699773 0.123 0.044 CID_9813763 | ||
| 0.196 | 0.033 | 0.196 | Anesthetic local | 0.179 0.038 CID_22943245 0.139 0.054 CID_154699793 0.139 0.054 CID_154699773 0.188 0.035 CID_9813763 | ||
| 0.199 | 0.038 | 0.215 | ATPase inhibitor | 0.198 0.039 CID_22943245 0.215 0.026 CID_154699793 0.152 0.099 CID_154699773 0.144 0.112 CID_9813763 | CID_154699793 | |
| 0.268 | 0.115 | 0.321 | Vasodilator, peripheral | 0.321 0.086 CID_22943245 0.314 0.09 CID_154699793 0.265 0.117 CID_154699773 0.194 0.183 CID_9813763 | CID_22943245 | |
| 0.155 | 0.003 | 0.155 | Potassium channel Kv1.1 blocker | 0.073 0.006 CID_22943245 0.08 0.005 CID_154699793 0.076 0.005 CID_154699773 0.05 0.013 CID_9813763 | ||
| 0.22 | 0.07 | 0.22 | Anticonvulsant | 0.179 0.1 CID_22943245 | ||
| 0.157 | 0.012 | 0.157 | Neuronal nicotinic receptor antagonist | 0.084 0.033 CID_22943245 0.15 0.012 CID_154699793 0.102 0.024 CID_154699773 0.075 0.041 CID_9813763 | ||
| 0.161 | 0.017 | 0.161 | Potassium channel activator | 0.113 0.037 CID_22943245 0.107 0.041 CID_154699793 0.104 0.044 CID_154699773 0.1 0.048 CID_9813763 | ||
| 0.181 | 0.038 | 0.189 | Cholinergic antagonist | 0.104 0.09 CID_22943245 0.178 0.039 CID_154699793 0.189 0.035 CID_154699773 0.111 0.083 CID_9813763 | CID_154699773 | |
| 0.274 | 0.132 | 0.274 | Calpain 2 inhibitor | 0.205 0.183 CID_22943245 | ||
| 0.176 | 0.038 | 0.185 | Acetylcholine antagonist | 0.101 0.091 CID_22943245 0.174 0.039 CID_154699793 0.185 0.035 CID_154699773 0.106 0.084 CID_9813763 | CID_154699773 | |
| 0.148 | 0.01 | 0.148 | TRPA1 antagonist | 0.054 0.052 CID_22943245 0.134 0.012 CID_154699793 0.076 0.028 CID_154699773 | ||
| 0.168 | 0.03 | 0.168 | Adrenaline antagonist | 0.135 0.039 CID_154699793 0.13 0.041 CID_154699773 0.106 0.05 CID_9813763 | ||
| 0.22 | 0.088 | 0.22 | Neuropeptide Y2 antagonist | 0.214 0.096 CID_22943245 0.187 0.145 CID_154699793 0.189 0.141 CID_154699773 0.189 0.141 CID_9813763 | ||
| 0.228 | 0.097 | 0.228 | Cardiotonic | 0.208 0.111 CID_154699793 0.185 0.134 CID_154699773 | ||
| 0.189 | 0.058 | 0.243 | Succinate dehydrogenase inhibitor | 0.243 0.025 CID_22943245 0.19 0.057 CID_154699793 0.206 0.045 CID_154699773 0.227 0.032 CID_9813763 | CID_22943245 | |
| 0.224 | 0.093 | 0.366 | Aldehyde oxidase inhibitor | 0.325 0.06 CID_22943245 0.353 0.055 CID_154699793 0.217 0.096 CID_154699773 0.366 0.052 CID_9813763 | CID_9813763 | |
| 0.196 | 0.07 | 0.196 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.177 | 0.053 | 0.185 | Neurotensin receptor agonist | 0.175 0.055 CID_22943245 0.185 0.044 CID_154699793 0.177 0.053 CID_154699773 0.16 0.079 CID_9813763 | CID_154699793 | |
| 0.149 | 0.027 | 0.155 | CDK3/cyclin E inhibitor | 0.152 0.025 CID_22943245 0.127 0.047 CID_154699793 0.155 0.023 CID_154699773 0.122 0.053 CID_9813763 | CID_154699773 | |
| 0.164 | 0.048 | 0.263 | Alpha-N-acetylglucosaminidase inhibitor | 0.263 0.021 CID_22943245 0.165 0.047 CID_154699793 0.187 0.038 CID_154699773 0.232 0.026 CID_9813763 | CID_22943245 | |
| 0.156 | 0.044 | 0.156 | Pregnane X receptor agonist | 0.141 0.071 CID_22943245 0.132 0.095 CID_154699793 | ||
| 0.217 | 0.105 | 0.327 | Interleukin agonist | 0.206 0.115 CID_22943245 0.211 0.11 CID_154699793 0.187 0.133 CID_154699773 0.327 0.036 CID_9813763 | CID_9813763 | |
| 0.146 | 0.037 | 0.176 | Sphingosine 1-phosphate receptor 4 antagonist | 0.162 0.024 CID_22943245 0.111 0.092 CID_154699793 0.115 0.081 CID_154699773 0.176 0.016 CID_9813763 | CID_9813763 | |
| 0.143 | 0.034 | 0.166 | Bronchodilator | 0.166 0.026 CID_154699793 0.138 0.036 CID_154699773 0.128 0.04 CID_9813763 | CID_154699793 | |
| 0.124 | 0.019 | 0.124 | Glutamate release inhibitor | 0.098 0.046 CID_22943245 0.093 0.055 CID_154699793 0.117 0.024 CID_154699773 0.085 0.074 CID_9813763 | ||
| 0.105 | 0.004 | 0.105 | Potassium channel (Inward rectifier) activator | 0.068 0.013 CID_22943245 0.066 0.014 CID_154699793 0.068 0.013 CID_154699773 0.085 0.007 CID_9813763 | ||
| 0.132 | 0.033 | 0.151 | HIV-1 integrase (Overall Integration) inhibitor | 0.151 0.025 CID_22943245 0.113 0.044 CID_154699793 0.132 0.033 CID_154699773 0.129 0.034 CID_9813763 | CID_22943245 | |
| 0.12 | 0.021 | 0.12 | Cannabinoid receptor antagonist | 0.077 0.042 CID_22943245 0.064 0.058 CID_154699793 0.1 0.029 CID_9813763 | ||
| 0.129 | 0.031 | 0.129 | Calcium antagonist | 0.094 0.053 CID_22943245 | ||
| 0.102 | 0.004 | 0.102 | Potassium channel (ATP-sensitive) activator | 0.065 0.012 CID_22943245 0.063 0.014 CID_154699793 0.065 0.012 CID_154699773 0.082 0.006 CID_9813763 | ||
| 0.114 | 0.017 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.103 0.025 CID_22943245 0.113 0.017 CID_154699793 0.116 0.015 CID_154699773 0.086 0.052 CID_9813763 | CID_154699773 | |
| 0.154 | 0.059 | 0.154 | Neuropeptide Y1 antagonist | 0.133 0.095 CID_22943245 0.151 0.064 CID_154699793 0.127 0.107 CID_154699773 | ||
| 0.136 | 0.042 | 0.136 | Calcium channel (voltage-sensitive) blocker | 0.095 0.091 CID_22943245 | ||
| 0.145 | 0.057 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.151 0.04 CID_22943245 0.142 0.066 CID_154699793 0.143 0.063 CID_154699773 0.147 0.052 CID_9813763 | CID_22943245 | |
| 0.163 | 0.077 | 0.21 | Growth hormone agonist | 0.21 0.055 CID_22943245 0.173 0.071 CID_154699793 0.188 0.064 CID_154699773 0.17 0.073 CID_9813763 | CID_22943245 | |
| 0.146 | 0.062 | 0.146 | Calcium channel blocker | |||
| 0.124 | 0.039 | 0.167 | Sphingomyelinase inhibitor | 0.167 0.018 CID_22943245 0.11 0.049 CID_154699793 0.099 0.061 CID_154699773 0.108 0.052 CID_9813763 | CID_22943245 | |
| 0.123 | 0.039 | 0.156 | Potassium channel (Ca-activated) activator | 0.156 0.026 CID_22943245 0.114 0.045 CID_154699793 0.12 0.041 CID_154699773 0.096 0.059 CID_9813763 | CID_22943245 | |
| 0.083 | 0.003 | 0.083 | Elastase 2A inhibitor | 0.06 0.004 CID_154699793 0.064 0.004 CID_154699773 0.06 0.004 CID_9813763 | ||
| 0.083 | 0.003 | 0.083 | Elastase 2 inhibitor | 0.06 0.004 CID_154699793 0.064 0.004 CID_154699773 0.06 0.004 CID_9813763 | ||
| 0.095 | 0.016 | 0.11 | Cannabinoid CB2 receptor antagonist | 0.063 0.028 CID_22943245 0.073 0.022 CID_154699793 0.11 0.013 CID_9813763 | CID_9813763 | |
| 0.096 | 0.017 | 0.096 | Phospholipase D inhibitor | 0.077 0.039 CID_22943245 0.071 0.052 CID_154699793 0.071 0.05 CID_154699773 0.083 0.029 CID_9813763 | ||
| 0.096 | 0.02 | 0.096 | Vanilloid 4 agonist | 0.088 0.028 CID_22943245 0.073 0.055 CID_154699793 0.078 0.045 CID_9813763 | ||
| 0.121 | 0.046 | 0.121 | Protease inhibitor | 0.116 0.05 CID_154699793 0.111 0.056 CID_154699773 0.105 0.062 CID_9813763 | ||
| 0.134 | 0.06 | 0.134 | Nav1.3 sodium channel blocker | 0.109 0.087 CID_22943245 0.13 0.064 CID_9813763 | ||
| 0.086 | 0.015 | 0.099 | Gonadotropin-releasing hormone receptor agonist | 0.099 0.01 CID_22943245 0.088 0.014 CID_154699793 0.078 0.019 CID_154699773 0.084 0.016 CID_9813763 | CID_22943245 | |
| 0.125 | 0.054 | 0.224 | Cystathionine beta-synthase inhibitor | 0.13 0.051 CID_22943245 0.2 0.024 CID_154699793 0.224 0.019 CID_154699773 0.113 0.064 CID_9813763 | CID_154699773 | |
| 0.122 | 0.052 | 0.122 | Falcipain 3 inhibitor | 0.09 0.082 CID_154699793 0.089 0.082 CID_154699773 0.091 0.08 CID_9813763 | ||
| 0.143 | 0.074 | 0.173 | Sphingosine 1-phosphate receptor 5 antagonist | 0.162 0.043 CID_22943245 0.141 0.077 CID_154699793 0.139 0.081 CID_154699773 0.173 0.03 CID_9813763 | CID_9813763 | |
| 0.174 | 0.105 | 0.203 | Neurotrophic factor enhancer | 0.189 0.088 CID_22943245 0.203 0.074 CID_154699793 0.165 0.116 CID_154699773 0.169 0.111 CID_9813763 | CID_154699793 | |
| 0.11 | 0.042 | 0.11 | Glutamate (mGluR7) agonist | 0.095 0.072 CID_22943245 | ||
| 0.131 | 0.063 | 0.131 | Cathepsin H inhibitor | 0.105 0.097 CID_22943245 | ||
| 0.117 | 0.049 | 0.159 | DOPA decarboxylase inhibitor | 0.141 0.026 CID_22943245 0.159 0.017 CID_154699793 0.138 0.029 CID_154699773 0.114 0.052 CID_9813763 | CID_154699793 | |
| 0.083 | 0.017 | 0.093 | MDM2 inhibitor | 0.093 0.009 CID_22943245 0.072 0.034 CID_154699793 0.063 0.062 CID_154699773 0.072 0.032 CID_9813763 | CID_22943245 | |
| 0.099 | 0.036 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.062 CID_22943245 0.089 0.054 CID_154699793 0.102 0.032 CID_154699773 0.09 0.051 CID_9813763 | CID_154699773 | |
| 0.151 | 0.088 | 0.182 | Arachidonic acid antagonist | 0.182 0.052 CID_22943245 0.151 0.087 CID_154699793 0.172 0.062 CID_154699773 0.172 0.063 CID_9813763 | CID_22943245 | |
| 0.068 | 0.005 | 0.103 | Beta adrenoreceptor agonist | 0.064 0.007 CID_22943245 0.093 0.004 CID_154699793 0.103 0.004 CID_154699773 0.084 0.004 CID_9813763 | CID_154699773 | |
| 0.086 | 0.023 | 0.121 | Beta adrenoreceptor antagonist | 0.091 0.02 CID_22943245 0.121 0.01 CID_154699793 0.111 0.013 CID_154699773 0.118 0.011 CID_9813763 | CID_154699793 | |
| 0.184 | 0.122 | 0.337 | Peptidyltransferase inhibitor | 0.319 0.019 CID_22943245 0.223 0.074 CID_154699793 0.215 0.081 CID_154699773 0.337 0.014 CID_9813763 | CID_9813763 | |
| 0.082 | 0.022 | 0.09 | Glutamate (mGluR6) antagonist | 0.09 0.015 CID_22943245 0.069 0.041 CID_154699793 0.072 0.036 CID_154699773 0.084 0.02 CID_9813763 | CID_22943245 | |
| 0.091 | 0.031 | 0.114 | Dopamine agonist | 0.114 0.022 CID_154699793 0.101 0.027 CID_154699773 | CID_154699793 | |
| 0.083 | 0.024 | 0.083 | Aryl hydrocarbon receptor antagonist | 0.078 0.028 CID_22943245 0.064 0.047 CID_154699793 0.066 0.043 CID_9813763 | ||
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | 0.07 0.052 CID_22943245 | ||
| 0.077 | 0.02 | 0.077 | Bombesin 3 receptor antagonist | 0.05 0.047 CID_22943245 0.06 0.033 CID_154699793 0.066 0.027 CID_154699773 | ||
| 0.12 | 0.063 | 0.12 | Calcium channel N-type blocker | |||
| 0.129 | 0.073 | 0.129 | Nav1.2 sodium channel blocker | 0.119 0.085 CID_9813763 | ||
| 0.107 | 0.052 | 0.159 | Creatine kinase inhibitor | 0.122 0.039 CID_22943245 0.138 0.029 CID_154699793 0.142 0.028 CID_154699773 0.159 0.02 CID_9813763 | CID_9813763 | |
| 0.075 | 0.021 | 0.095 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 CID_22943245 0.095 0.011 CID_154699793 0.085 0.015 CID_154699773 0.095 0.011 CID_9813763 | CID_9813763 | |
| 0.078 | 0.024 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.08 0.023 CID_22943245 0.093 0.017 CID_154699793 0.08 0.023 CID_154699773 0.071 0.033 CID_9813763 | CID_154699793 | |
| 0.09 | 0.036 | 0.093 | GABA aminotransferase inhibitor | 0.093 0.033 CID_22943245 0.093 0.032 CID_154699793 0.089 0.036 CID_154699773 0.082 0.043 CID_9813763 | CID_154699793 | |
| 0.138 | 0.085 | 0.161 | Adenylate cyclase stimulant | 0.145 0.071 CID_22943245 0.161 0.046 CID_154699793 0.147 0.068 CID_154699773 | CID_154699793 | |
| 0.177 | 0.124 | 0.224 | Vasodilator | 0.196 0.108 CID_22943245 0.224 0.087 CID_154699793 0.222 0.088 CID_154699773 0.197 0.107 CID_9813763 | CID_154699793 | |
| 0.085 | 0.032 | 0.095 | GABA B receptor agonist | 0.095 0.02 CID_22943245 0.094 0.021 CID_154699793 0.086 0.031 CID_154699773 0.087 0.029 CID_9813763 | CID_22943245 | |
| 0.137 | 0.085 | 0.137 | Thiol protease inhibitor | 0.125 0.106 CID_22943245 0.122 0.113 CID_9813763 | ||
| 0.103 | 0.052 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 CID_22943245 | CID_22943245 | |
| 0.083 | 0.034 | 0.142 | Sphingosine 1-phosphate receptor 4 agonist | 0.116 0.018 CID_22943245 0.069 0.045 CID_154699793 0.061 0.054 CID_154699773 0.142 0.01 CID_9813763 | CID_9813763 | |
| 0.072 | 0.025 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 CID_154699793 | ||
| 0.041 | 0.005 | 0.041 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.082 | 0.046 | 0.142 | Catalase inhibitor | 0.137 0.029 CID_22943245 0.079 0.048 CID_154699793 0.142 0.028 CID_9813763 | CID_9813763 | |
| 0.15 | 0.114 | 0.203 | Anesthetic general | 0.203 0.073 CID_22943245 0.137 0.128 CID_154699793 0.177 0.089 CID_9813763 | CID_22943245 | |
| 0.124 | 0.088 | 0.145 | Sphingosine 1-phosphate receptor 2 antagonist | 0.134 0.066 CID_22943245 0.129 0.077 CID_154699793 0.126 0.083 CID_154699773 0.145 0.048 CID_9813763 | CID_9813763 | |
| 0.06 | 0.024 | 0.079 | Beta 2 adrenoreceptor antagonist | 0.06 0.024 CID_22943245 0.078 0.013 CID_154699793 0.073 0.015 CID_154699773 0.079 0.012 CID_9813763 | CID_9813763 | |
| 0.065 | 0.03 | 0.081 | Beta 2 adrenoreceptor agonist | 0.066 0.027 CID_22943245 0.075 0.012 CID_154699793 0.081 0.008 CID_154699773 0.073 0.015 CID_9813763 | CID_154699773 | |
| 0.069 | 0.035 | 0.069 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 CID_9813763 | ||
| 0.092 | 0.061 | 0.092 | Falcipain inhibitor | |||
| 0.09 | 0.059 | 0.09 | Falcipain 2 inhibitor | |||
| 0.076 | 0.048 | 0.124 | Glutamate decarboxylase inhibitor | 0.097 0.032 CID_22943245 0.124 0.019 CID_154699793 0.103 0.028 CID_154699773 0.086 0.039 CID_9813763 | CID_154699793 | |
| 0.047 | 0.02 | 0.047 | Alpha 1L adrenoreceptor agonist | |||
| 0.059 | 0.033 | 0.063 | Thromboxane antagonist | 0.063 0.03 CID_22943245 | CID_22943245 | |
| 0.094 | 0.068 | 0.137 | UDP-glucose 4-epimerase inhibitor | 0.128 0.038 CID_22943245 0.121 0.042 CID_154699793 0.137 0.034 CID_154699773 0.114 0.047 CID_9813763 | CID_154699773 | |
| 0.081 | 0.057 | 0.081 | Ca(v)3.1 blocker | 0.077 0.072 CID_154699793 | ||
| 0.095 | 0.07 | 0.117 | Anabolic | 0.094 0.072 CID_22943245 0.117 0.042 CID_154699793 0.11 0.05 CID_154699773 | CID_154699793 | |
| 0.076 | 0.053 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.087 0.034 CID_22943245 0.072 0.065 CID_154699773 0.082 0.043 CID_9813763 | CID_22943245 | |
| 0.04 | 0.017 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.05 0.007 CID_22943245 0.04 0.017 CID_154699773 0.053 0.005 CID_9813763 | CID_9813763 | |
| 0.073 | 0.05 | 0.073 | Cathepsin G inhibitor | |||
| 0.066 | 0.044 | 0.077 | Cannabinoid receptor agonist | 0.062 0.047 CID_22943245 0.077 0.037 CID_9813763 | CID_9813763 | |
| 0.06 | 0.039 | 0.06 | Ca(v)3.2 blocker | |||
| 0.056 | 0.036 | 0.068 | Sphingosine 1-phosphate receptor 1 antagonist | 0.068 0.02 CID_22943245 0.051 0.05 CID_154699793 0.054 0.042 CID_154699773 0.062 0.027 CID_9813763 | CID_22943245 | |
| 0.053 | 0.034 | 0.056 | Thromboxane A2 antagonist | 0.056 0.031 CID_22943245 | CID_22943245 | |
| 0.105 | 0.086 | 0.113 | Interleukin 8 antagonist | 0.113 0.072 CID_22943245 0.103 0.091 CID_154699773 | CID_22943245 | |
| 0.055 | 0.035 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.091 | 0.073 | 0.091 | Electrolyte absorption antagonist | |||
| 0.078 | 0.06 | 0.078 | Glycine receptor antagonist | |||
| 0.121 | 0.103 | 0.177 | Diuretic | 0.133 0.092 CID_22943245 0.177 0.056 CID_9813763 | CID_9813763 | |
| 0.094 | 0.076 | 0.119 | Expectorant | 0.11 0.059 CID_22943245 0.118 0.052 CID_154699793 0.119 0.051 CID_154699773 | CID_154699773 | |
| 0.051 | 0.034 | 0.051 | Prolyl endopeptidase inhibitor | |||
| 0.04 | 0.025 | 0.04 | Melanocortin 1 antagonist | |||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | 0.03 0.017 CID_154699793 0.027 0.024 CID_154699773 | ||
| 0.049 | 0.034 | 0.049 | HCV NS3/NS4A protease inhibitor | |||
| 0.061 | 0.046 | 0.094 | NMDA receptor agonist | 0.094 0.021 CID_22943245 0.061 0.045 CID_9813763 | CID_22943245 | |
| 0.095 | 0.081 | 0.095 | Factor V inhibitor | |||
| 0.042 | 0.028 | 0.042 | Cathepsin F inhibitor | |||
| 0.064 | 0.051 | 0.074 | Potassium channel (ATP-sensitive) blocker | 0.074 0.035 CID_9813763 | CID_9813763 | |
| 0.064 | 0.052 | 0.078 | Potassium channel large-conductance Ca-activated activator | 0.078 0.037 CID_22943245 0.064 0.053 CID_154699793 0.068 0.046 CID_154699773 0.064 0.052 CID_9813763 | CID_22943245 | |
| 0.048 | 0.037 | 0.048 | Chemokine receptor agonist | |||
| 0.095 | 0.085 | 0.116 | Mucolytic | 0.112 0.063 CID_22943245 0.114 0.06 CID_154699793 0.116 0.058 CID_154699773 | CID_154699773 | |
| 0.036 | 0.027 | 0.036 | 5-Alpha-reductase inhibitor | 0.033 0.031 CID_154699773 0.033 0.031 CID_9813763 | ||
| 0.078 | 0.069 | 0.079 | Thioredoxin reductase inhibitor | 0.076 0.073 CID_22943245 0.079 0.066 CID_154699793 | CID_154699793 | |
| 0.114 | 0.106 | 0.114 | Nav1.6 sodium channel blocker | |||
| 0.057 | 0.049 | 0.092 | NMDA receptor glycine site agonist | 0.092 0.021 CID_22943245 0.059 0.047 CID_9813763 | CID_22943245 | |
| 0.026 | 0.019 | 0.036 | CXC chemokine 2 receptor antagonist | 0.033 0.012 CID_22943245 0.029 0.015 CID_154699793 0.024 0.022 CID_154699773 0.036 0.009 CID_9813763 | CID_9813763 | |
| 0.054 | 0.048 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.042 CID_22943245 0.069 0.027 CID_9813763 | CID_9813763 | |
| 0.039 | 0.035 | 0.055 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.037 CID_22943245 0.046 0.02 CID_154699793 0.055 0.01 CID_154699773 | CID_154699773 | |
| 0.145 | 0.141 | 0.181 | Insulin sensitizer | 0.181 0.095 CID_22943245 0.145 0.141 CID_154699793 0.152 0.13 CID_154699773 | CID_22943245 | |
| 0.08 | 0.076 | 0.103 | NADH dehydrogenase inhibitor | 0.084 0.067 CID_22943245 0.083 0.069 CID_154699793 0.103 0.041 CID_154699773 0.087 0.061 CID_9813763 | CID_154699773 | |
| 0.083 | 0.079 | 0.094 | Aminopeptidase B inhibitor | 0.086 0.076 CID_22943245 0.087 0.075 CID_154699773 0.094 0.069 CID_9813763 | CID_9813763 | |
| 0.041 | 0.038 | 0.041 | Histamine H1 receptor agonist | |||
| 0.107 | 0.104 | 0.107 | Cytokine production inhibitor | |||
| 0.03 | 0.027 | 0.03 | CXC chemokine receptor agonist | |||
| 0.034 | 0.031 | 0.035 | Factor XIIIa inhibitor | 0.035 0.029 CID_22943245 | CID_22943245 | |
| 0.052 | 0.05 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.048 | 0.046 | 0.048 | Elastase inhibitor | |||
| 0.039 | 0.038 | 0.039 | GABA B receptor antagonist | |||
| 0.049 | 0.048 | 0.049 | Argininosuccinate synthase inhibitor | |||
| 0.124 | 0.123 | 0.148 | MAP kinase 3 inhibitor | 0.148 0.07 CID_22943245 | CID_22943245 | |
| 0.02 | 0.02 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.013 CID_22943245 0.025 0.013 CID_154699793 | CID_154699793 | |
| 0.111 | 0.113 | 0.14 | Vanilloid 1 agonist | 0.112 0.109 CID_22943245 0.124 0.079 CID_154699793 0.14 0.05 CID_154699773 0.114 0.104 CID_9813763 | CID_154699773 | |
| 0.032 | 0.034 | 0.038 | Glutamate (mGluR3) antagonist | 0.038 0.023 CID_22943245 | CID_22943245 | |
| 0.039 | 0.042 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.033 CID_22943245 | CID_22943245 | |
| 0.062 | 0.066 | 0.073 | Aminopeptidase I inhibitor | 0.067 0.057 CID_22943245 0.073 0.05 CID_9813763 | CID_9813763 | |
| 0.039 | 0.044 | 0.041 | Glutamate (mGluR group III) antagonist | 0.041 0.037 CID_22943245 | CID_22943245 | |
| 0.049 | 0.054 | 0.073 | Cannabinoid CB1 receptor agonist | 0.059 0.044 CID_22943245 0.073 0.033 CID_9813763 | CID_9813763 | |
| 0.035 | 0.044 | 0.054 | Glycine transporter 2 inhibitor | 0.054 0.028 CID_154699793 | CID_154699793 | |
| 0.057 | 0.066 | 0.108 | Histidine decarboxylase inhibitor | 0.097 0.033 CID_154699793 0.108 0.029 CID_154699773 | CID_154699773 | |
| 0.04 | 0.05 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.065 0.028 CID_22943245 0.07 0.026 CID_9813763 | CID_9813763 | |
| 0.032 | 0.043 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.03 CID_154699773 | CID_154699773 | |
| 0.034 | 0.047 | 0.041 | HIV-1 protease inhibitor | 0.041 0.033 CID_22943245 | CID_22943245 | |
| 0.075 | 0.087 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.068 CID_154699793 | CID_154699793 | |
| 0.027 | 0.04 | 0.037 | Glutamate (mGluR3) agonist | 0.03 0.029 CID_22943245 0.037 0.014 CID_154699793 0.033 0.022 CID_154699773 0.034 0.019 CID_9813763 | CID_154699793 | |
| 0.057 | 0.072 | 0.061 | Calcium channel P-type blocker | 0.061 0.052 CID_22943245 | CID_22943245 | |
| 0.05 | 0.064 | 0.058 | Pregnane X receptor antagonist | 0.058 0.036 CID_154699793 0.054 0.046 CID_154699773 | CID_154699793 | |
| 0.16 | 0.175 | 0.172 | RNA-directed DNA polymerase inhibitor | 0.172 0.149 CID_154699793 0.165 0.163 CID_154699773 | CID_154699793 | |
| 0.09 | 0.107 | 0.16 | Amylase inhibitor | 0.16 0.059 CID_22943245 0.151 0.064 CID_154699793 0.12 0.081 CID_154699773 0.138 0.07 CID_9813763 | CID_22943245 | |
| 0.043 | 0.066 | 0.076 | Glucagon-like peptide 1 agonist | 0.076 0.037 CID_22943245 | CID_22943245 | |
| 0.081 | 0.105 | 0.141 | Adenylate cyclase inhibitor | 0.116 0.071 CID_22943245 0.093 0.091 CID_154699793 0.141 0.051 CID_154699773 | CID_154699773 | |
| 0.097 | 0.123 | 0.122 | Alkaline phosphatase inhibitor | 0.122 0.084 CID_154699793 | CID_154699793 | |
| 0.117 | 0.143 | 0.148 | Interferon gamma antagonist | 0.148 0.08 CID_154699793 0.125 0.121 CID_154699773 | CID_154699793 | |
| 0.179 | 0.206 | 0.227 | Antithrombotic | 0.227 0.146 CID_22943245 0.199 0.179 CID_154699793 | CID_22943245 | |
| 0.012 | 0.041 | 0.041 | Follicle-stimulating hormone agonist | 0.041 0.007 CID_22943245 0.024 0.014 CID_9813763 | CID_22943245 | |
| 0.113 | 0.142 | 0.222 | Heat shock protein 90 alpha antagonist | 0.185 0.059 CID_154699793 0.222 0.038 CID_154699773 | CID_154699773 | |
| 0.032 | 0.061 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.031 CID_22943245 | CID_22943245 | |
| 0.095 | 0.124 | 0.161 | Sphingosine 1-phosphate receptor 2 agonist | 0.161 0.02 CID_9813763 | CID_9813763 | |
| 0.149 | 0.18 | 0.247 | Hypoglycemic | 0.226 0.092 CID_22943245 0.218 0.097 CID_154699793 0.169 0.148 CID_154699773 0.247 0.079 CID_9813763 | CID_9813763 | |
| 0.086 | 0.119 | 0.097 | Microtubule formation inhibitor | 0.097 0.096 CID_154699773 | CID_154699773 | |
| 0.135 | 0.169 | 0.205 | Immunostimulant | 0.201 0.119 CID_22943245 0.205 0.117 CID_154699793 0.164 0.143 CID_154699773 0.194 0.124 CID_9813763 | CID_154699793 | |
| 0.045 | 0.08 | 0.056 | Purinergic P2X1 antagonist | 0.056 0.05 CID_154699793 | CID_154699793 | |
| 0.088 | 0.123 | 0.102 | Cyclooxygenase 3 inhibitor | 0.102 0.1 CID_22943245 | CID_22943245 | |
| 0.087 | 0.125 | 0.111 | Aldehyde dehydrogenase inhibitor | 0.109 0.084 CID_22943245 0.111 0.082 CID_154699793 0.102 0.095 CID_9813763 | CID_154699793 | |
| 0.045 | 0.084 | 0.097 | Heat shock protein 90 beta antagonist | 0.081 0.02 CID_154699793 0.097 0.012 CID_154699773 | CID_154699773 | |
| 0.126 | 0.165 | 0.165 | Phospholipase C inhibitor | 0.153 0.101 CID_22943245 0.165 0.08 CID_154699793 0.14 0.128 CID_154699773 0.165 0.08 CID_9813763 | CID_9813763 | |
| 0.093 | 0.132 | 0.108 | Transcription factor STAT6 inhibitor | 0.108 0.085 CID_154699773 | CID_154699773 | |
| 0.045 | 0.085 | 0.093 | Phenylalanine 4-hydroxylase inhibitor | 0.079 0.038 CID_22943245 0.073 0.043 CID_154699793 0.06 0.057 CID_154699773 0.093 0.029 CID_9813763 | CID_9813763 | |
| 0.039 | 0.079 | 0.072 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 CID_22943245 0.072 0.033 CID_9813763 | CID_9813763 | |
| 0.026 | 0.067 | 0.049 | Phosphorylase inhibitor | 0.049 0.031 CID_22943245 | CID_22943245 | |
| 0.015 | 0.056 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 CID_9813763 | CID_9813763 | |
| 0.017 | 0.058 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.018 CID_9813763 | CID_9813763 | |
| 0.028 | 0.073 | 0.05 | Neuropeptide agonist | 0.05 0.042 CID_22943245 | CID_22943245 | |
| 0.023 | 0.075 | 0.04 | Dopamine D5 agonist | 0.04 0.028 CID_154699793 | CID_154699793 | |
| 0.089 | 0.147 | 0.344 | Peroxidase inhibitor | 0.114 0.106 CID_22943245 0.217 0.055 CID_154699793 0.344 0.029 CID_154699773 | CID_154699773 | |
| 0.148 | 0.21 | 0.222 | 12-Lipoxygenase inhibitor | 0.222 0.128 CID_154699793 0.193 0.159 CID_154699773 | CID_154699793 | |
| 0.023 | 0.086 | 0.044 | Sphingosine 1-phosphate receptor 1 agonist | 0.039 0.033 CID_22943245 0.044 0.027 CID_9813763 | CID_9813763 | |
| 0.051 | 0.116 | 0.072 | Glycine receptor agonist | 0.072 0.05 CID_22943245 | CID_22943245 | |
| 0.034 | 0.107 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.048 CID_22943245 0.05 0.048 CID_9813763 | CID_9813763 | |
| 0.041 | 0.118 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.036 CID_154699793 | CID_154699793 | |
| 0.217 | 0.295 | 0.254 | Caspase 9 stimulant | 0.254 0.248 CID_154699793 | CID_154699793 | |
| 0.101 | 0.183 | 0.135 | Melanin inhibitor | 0.135 0.106 CID_154699793 0.131 0.112 CID_154699773 | CID_154699793 | |
| 0.141 | 0.223 | 0.203 | DNA synthesis inhibitor | 0.192 0.135 CID_22943245 0.186 0.144 CID_154699793 0.201 0.121 CID_154699773 0.203 0.118 CID_9813763 | CID_9813763 | |
| 0.009 | 0.091 | 0.095 | Sphingosine 1-phosphate receptor 3 agonist | 0.052 0.015 CID_154699773 0.095 0.007 CID_9813763 | CID_9813763 | |
| 0.055 | 0.138 | 0.097 | Alcohol dehydrogenase inhibitor | 0.097 0.055 CID_154699793 | CID_154699793 | |
| 0.012 | 0.095 | 0.103 | Bradykinin antagonist | 0.103 0.006 CID_22943245 | CID_22943245 | |
| 0.166 | 0.25 | 0.232 | Toll-Like receptor 7 agonist | 0.232 0.165 CID_9813763 | CID_9813763 | |
| 0.064 | 0.148 | 0.086 | Estrogen-related receptor beta agonist | 0.086 0.05 CID_154699793 | CID_154699793 | |
| 0.165 | 0.251 | 0.253 | Toll-Like receptor agonist | 0.253 0.145 CID_9813763 | CID_9813763 | |
| 0.022 | 0.11 | 0.041 | Sphingosine 1-phosphate receptor agonist | 0.041 0.036 CID_9813763 | CID_9813763 | |
| 0.034 | 0.134 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.029 CID_9813763 | CID_9813763 | |
| 0.087 | 0.193 | 0.192 | Heat shock protein 90 antagonist | 0.154 0.071 CID_154699793 0.192 0.042 CID_154699773 | CID_154699773 | |
| 0.012 | 0.124 | 0.033 | Catechol O-methyltransferase inhibitor | 0.033 0.023 CID_154699793 | CID_154699793 | |
| 0.06 | 0.175 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.078 CID_22943245 | CID_22943245 | |
| 0.025 | 0.148 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.038 CID_154699773 | CID_154699773 | |
| 0.102 | 0.232 | 0.177 | Tumour necrosis factor alpha release inhibitor | 0.177 0.129 CID_9813763 | CID_9813763 | |
| 0.054 | 0.189 | 0.079 | Transcription factor NF kappa B stimulant | 0.079 0.073 CID_154699793 | CID_154699793 | |
| 0.018 | 0.175 | 0.09 | Opioid mu receptor antagonist | 0.09 0.035 CID_22943245 | CID_22943245 | |
| 0.116 | 0.274 | 0.196 | Transcription factor NF kappa B inhibitor | 0.196 0.172 CID_154699793 | CID_154699793 | |
| 0.038 | 0.198 | 0.108 | Opioid antagonist | 0.108 0.042 CID_22943245 | CID_22943245 | |
| 0.004 | 0.177 | 0.057 | Bradykinin B2 receptor antagonist | 0.057 0.005 CID_22943245 | CID_22943245 | |
| 0.053 | 0.254 | 0.081 | Hematopoietic | 0.081 0.071 CID_22943245 | CID_22943245 | |
| 0.012 | 0.226 | 0.054 | Opioid agonist | 0.054 0.035 CID_22943245 | CID_22943245 | |
| 0.009 | 0.231 | 0.057 | Opioid mu receptor agonist | 0.057 0.025 CID_22943245 | CID_22943245 | |
| 0.009 | 0.242 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.014 CID_22943245 | CID_22943245 | |
| 0.125 | 0.376 | 0.208 | Interleukin 2 agonist | 0.208 0.176 CID_22943245 | CID_22943245 | |
| 0.059 | 0.34 | 0.208 | Free radical scavenger | 0.208 0.092 CID_154699793 | CID_154699793 | |
| 0.038 | 0.369 | 0.155 | Angiogenesis stimulant | 0.155 0.119 CID_22943245 | CID_22943245 | |
| 0.041 | 0.402 | 0.126 | Farnesoid X receptor antagonist | 0.126 0.091 CID_154699793 | CID_154699793 | |
| 0.062 | 0.428 | 0.398 | Immunosuppressant | 0.398 0.064 CID_9813763 | CID_9813763 | |
| 0.035 | 0.504 | 0.17 | Antioxidant | 0.17 0.142 CID_154699793 | CID_154699793 | |
| 0.008 | 0.673 | 0.106 | Estrogen receptor beta antagonist | 0.102 0.06 CID_154699793 0.106 0.054 CID_154699773 | CID_154699773 | |
| 0.01 | 0.717 | 0.112 | Estrogen antagonist | 0.112 0.071 CID_154699793 0.111 0.073 CID_154699773 | CID_154699793 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |